Leaders confident they have support for a public option in final House health bill

CQ Politics: "'We're right around 218 (votes) for a robust public option,' Democratic Caucus Chairman John B. Larson of Connecticut said early Wednesday afternoon as Majority Whip James E. Clyburn , D-S.C., was working to complete a whip count of Democrats that Speaker Nancy Pelosi , D-Calif., asked for on Tuesday." There are 256 Democrats in the House, but some moderates have balked at inclusion of a public plan, "especially one linked to Medicare rates," CQ Politics reports (10/21).

CongressDaily: "But a Democratic aide said leaders needed to hit a higher number to account for members who would support a 'robust' public option but might object to other parts of the bill." Leaders are set to announce an agreement today that would call for two studies at the Institute of Medicine to determine reimbursement rates. "A Democratic aide said the studies would account for several factors, including geography and the demographics of communities. The studies' recommendations would go into effect unless both chambers of Congress passed resolutions of disapproval condemning them" (Hunt, 10/22).

Roll Call reports that details are still being worked out, but a proposal would provide about $8 billion extra for states with high quality outcomes and low costs. Many still have questions about reimbursement rates, and others have concerns about the bill's tax treatment and impact on small business (Dennis, 10/22).

Pelosi's support of a "robust" public plan is drawing centrist complaints from the Blue Dog Democrats, who are hinting they may have the votes to stop her, The Hill reports. "'...there's been less than 12 Blue Dogs willing to support this,' said Rep. Jim Matheson (D-Utah), the Blue Dogs' co-chairman for communications. The number 12 is significant, because it indicates that 40 of the 52 Blue Dogs might be ready to vote for it. If 39 or more Democrats were to join all Republicans in voting against a bill, it would fail on the House floor" (Soraghan, 10/21).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study warns of high Medicare costs for semaglutide even with restrictive CVD definition